Canine Stem Cell Therapy Market Analysis Of Growth, Trends Progress And Challenges Till Upcoming Year – Jewish Life News

The Canine Stem Cell Therapy market study offers an in-depth analysis of the current market trends influencing this business vertical. The study also includes market valuation, market size, revenue forecasts, geographical spectrum and SWOT Analysis of the industry. In addition, the report depicts key challenges and growth opportunities faced by the industry bigwigs, in consort with their product offerings and business strategies.

A collective analysis of Canine Stem Cell Therapy market offering an exhaustive study based on current trends influencing this vertical across various geographies has been provided in the report. Also, this research study estimates this space to accrue considerable income during the projected period, with the help of a plethora of driving forces that will boost the industry trends during the forecast duration. Snippets of these influences, in tandem with countless other dynamics relating to the Canine Stem Cell Therapy market, like the risks that are predominant across this industry along with the growth prospects existing in Canine Stem Cell Therapy market, have also been charted out in the report.

Request Sample Report @ https://www.xploremr.com/connectus/sample/2360

One of the most dynamic points that makes the Canine Stem Cell Therapy market report worth a purchase is the widespread synopsis of the competitive range of the vertical. The study proficiently separates the Canine Stem Cell Therapy market into

Market Taxonomy

The global canine stem cell therapy market has been segmented into:

Product Type:

Application:

End User:

Region:

, according to the competitive hierarchy. These firms have been competing with one another to gain a near-dominant status in the industry.

Get Discount On This Report @ https://www.xploremr.com/connectus/check-discount/2360

The report provides extensive data concerning the market share that each one of these companies presently gather throughout this business, followed by the market share that they are anticipated to acquire by the end of the predicted timeframe. Also, the report expounds on details relating to the goods manufactured by these firms, that would help new industry participants and major stakeholders work on their competition and portfolio strategies. In addition, their policymaking process is likely to get easier since the Canine Stem Cell Therapy market report also enumerates an idea of the trends in product prices and the revenue margins of all the major companies partaking in the industry share.

Queries that the Canine Stem Cell Therapy market report answers in respect of the regional landscape of the business domain:

The geographical landscape, according to the report, is divided into North America, Europe, Asia-Pacific, South America & Middle East and Africa. Which among these regions is more likely to amass maximum market share over the forecast duration

How much is the sales evaluations of each market player in question Also, how are the revenue statistics regarding the present market scenario

How much profit does each geography hold at present

How many proceeds will every zone including North America, Europe, Asia-Pacific, South America & Middle East and Africa account for, over the projected timeframe

How much growth rate is each region estimated to exhibit by the end of the estimated timeline

You can Buy This Report from Here @ https://www.xploremr.com/cart/2360/SL

Significant takeaways from the study:

The Canine Stem Cell Therapy market report hosts excess deliverables that may be highly advantageous. Say for instance, the report emphasizes information regarding market competition trends extremely essential data subject to contender intelligence and the current industry drifts that would enable shareholders to compete and take advantage of the biggest growth opportunities in the Canine Stem Cell Therapy market.

Another vital takeaway from the report can be accredited to the industry concentration rate that could help stakeholders to speculate on the existing sales dominance and the probable trends of the forthcoming years.

Additional deliverables mentioned in the report include details pertaining to the sales channels deployed by prominent sellers in order to retail their status in the industry, including direct and indirect marketing.

Read the original post:
Canine Stem Cell Therapy Market Analysis Of Growth, Trends Progress And Challenges Till Upcoming Year - Jewish Life News

Global Cell Therapy Technologies Market : Industry Analysis and Forecast (2019-2026) – MR Invasion

Global Cell Therapy Technologies Market was valued US$ 12 billion in 2018 and is expected to reach US$ 35 billion by 2026, at CAGR of 12.14 %during forecast period.

REQUEST FOR FREE SAMPLE REPORT: https://www.maximizemarketresearch.com/request-sample//31531/

The objective of the report is to present comprehensive assessment projections with a suitable set of assumptions and methodology. The report helps in understanding Global Cell Therapy Technologies Market dynamics, structure by identifying and analyzing the market segments and projecting the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, growth strategies, and regional presence. To understand the market dynamics and by region, the report has covered the PEST analysis by region and key economies across the globe, which are supposed to have an impact on market in forecast period. PORTERs analysis, and SVOR analysis of the market as well as detailed SWOT analysis of key players has been done to analyze their strategies. The report will to address all questions of shareholders to prioritize the efforts and investment in the near future to the emerging segment in the Global Cell Therapy Technologies Market.

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

Global Cell Therapy Technologies Market: Overview

Cell therapy is a transplantation of live human cells to replace or repair damaged tissue and/or cells. With the help of new technologies, limitless imagination, and innovative products, many different types of cells may be used as part of a therapy or treatment for different types of diseases and conditions. Celltherapy technologies plays key role in the practice of medicine such as old fashioned bone marrow transplants is replaced by Hematopoietic stem cell transplantation, capacity of cells in drug discovery. Cell therapy overlap with different therapies like, gene therapy, tissue engineering, cancer vaccines, regenerative medicine, and drug delivery. Establishment of cell banking facilities and production, storage, and characterization of cells are increasing volumetric capabilities of the cell therapy market globally. Initiation of constructive guidelines for cell therapy manufacturing and proven effectiveness of products, these are primary growth stimulants of the market.

DO INQUIRY BEFORE PURCHASING REPORT HERE: https://www.maximizemarketresearch.com/inquiry-before-buying//31531/

Global Cell Therapy Technologies Market: Drivers and Restraints

The growth of cell therapy technologies market is highly driven by, increasing demand for clinical trials on oncology-oriented cell-based therapy, demand for advanced cell therapy instruments is increasing, owing to its affordability and sustainability, government and private organization , investing more funds in cell-based research therapy for life-style diseases such as diabetes, decrease in prices of stem cell therapies are leading to increased tendency of buyers towards cell therapy, existing companies are collaborating with research institute in order to best fit into regulatory model for cell therapies.Moreover, Healthcare practitioners uses stem cells obtained from bone marrow or blood for treatment of patients with cancer, blood disorders, and immune-related disorders and Development in cell banking facilities and resultant expansion of production, storage, and characterization of cells, these factors will drive the market of cell therapy technologies during forecast period.

On the other hand, the high cost of cell-based research and some ethical issue & legally controversial, are expected to hamper market growth of Cell Therapy Technologies during the forecast period

AJune 2016, there were around 351 companies across the U.S. that were engaged in advertising unauthorized stem cell treatments at their clinics. Such clinics boosted the revenue in this market.in August 2017, the U.S. FDA announced increased enforcement of regulations and oversight of clinics involved in practicing unapproved stem cell therapies. This might hamper the revenue generation during the forecast period; nevertheless, it will allow safe and effective use of stem cell therapies.

Global Cell Therapy Technologies Market: Segmentation Analysis

On the basis of product, the consumables segment had largest market share in 2018 and is expected to drive the cell therapy instruments market during forecast period at XX % CAGR owing to the huge demand for consumables in cell-based experiments and cancer research and increasing number of new product launches and consumables are essential for every step of cell processing. This is further expected to drive their adoption in the market. These factors will boost the market of Cell Therapy Technologies Market in upcoming years.

On the basis of process, the cell processing had largest market share in 2018 and is expected to grow at the highest CAGR during the forecast period owing to in cell processing stage,a use of cell therapy instruments and media at highest rate, mainly in culture media processing. This is a major factor will drive the market share during forecast period.

Global Cell Therapy Technologies Market: Regional Analysis

North America to held largest market share of the cell therapy technologies in 2018 and expected to grow at highest CAGR during forecast period owing to increasing R&D programs in the pharmaceutical and biotechnology industries. North America followed by Europe, Asia Pacific and Rest of the world (Row).Scope of Global Cell Therapy Technologies Market

Global Cell Therapy Technologies Market, by Product

Consumables Equipment Systems & SoftwareGlobal Cell Therapy Technologies Market, by Cell Type

Human Cells Animal CellsGlobal Cell Therapy Technologies Market, by Process Stages

Cell Processing Cell Preservation, Distribution, and Handling Process Monitoring and Quality ControlGlobal Cell Therapy Technologies Market, by End Users

Life Science Research Companies Research InstitutesGlobal Cell Therapy Technologies Market, by Region

North America Europe Asia Pacific Middle East & Africa South AmericaKey players operating in the Global Cell Therapy Technologies Market

Beckman Coulter, Inc. Becton Dickinson and Company GE Healthcare Lonza Merck KGaA MiltenyiBiotec STEMCELL Technologies, Inc. Terumo BCT, Inc. Thermo Fisher Scientific, Inc. Sartorius AG

MAJOR TOC OF THE REPORT

Chapter One: Cell Therapy Technologies Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three: Global Cell Therapy Technologies Market Competition, by Players

Chapter Four: Global Cell Therapy Technologies Market Size by Regions

Chapter Five: North America Cell Therapy Technologies Revenue by Countries

Chapter Six: Europe Cell Therapy Technologies Revenue by Countries

Chapter Seven: Asia-Pacific Cell Therapy Technologies Revenue by Countries

Chapter Eight: South America Cell Therapy Technologies Revenue by Countries

Chapter Nine: Middle East and Africa Revenue Cell Therapy Technologies by Countries

Chapter Ten: Global Cell Therapy Technologies Market Segment by Type

Chapter Eleven: Global Cell Therapy Technologies Market Segment by Application

Chapter Twelve: Global Cell Therapy Technologies Market Size Forecast (2019-2026)

Browse Full Report with Facts and Figures of Cell Therapy Technologies Market Report at: https://www.maximizemarketresearch.com/market-report/global-cell-therapy-technologies-market/31531/

About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Vikas Godage

Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: sales@maximizemarketresearch.com

Contact: +919607065656/ +919607195908

Website:www.maximizemarketresearch.com

Original post:
Global Cell Therapy Technologies Market : Industry Analysis and Forecast (2019-2026) - MR Invasion

Inside the twisted world of ‘rapist’ designer Peter Nygard: book – The Loppy

Peter Nygard, the flamboyant Canadian fashion mogul, built a nearly billion-dollar fortune hawking slacks and blouses at Sears, Walmart and his own store in Times Square. Known as a hard-partying Peter Pan, the man Forbes dubbed The Polyester Phenom was often surrounded by young women and threw legendary parties at his homes in the Bahamas and Los Angeles.

But it all came to a halt in February when the FBI raided Nygards Manhattan office. The bust came just a week after 10 unidentified women filed a federal lawsuit accusing the 78-year-old of a decades-long sex-trafficking scheme in which he recruited, lured, and enticed young, impressionable and often impoverished children and women, with cash payments and false promises of lucrative modeling opportunities only to, allegedly, sexually assault and rape them. On April 22, 36 more women joined a class-action complaint against Nygard.

The new book Predator King: Peter Nygards Dark Life of Rape, Drugs and Blackmail (Hot Books) by Melissa Cronin tells this dark story. (Nygards lawyer, who has sent a cease-and-desist letter to the books publisher, told The Post: Predator King recklessly presents a one-sided, unreliable, and wholly misleading portrayal of the allegations against Mr. Nygard.) Here, an adapted excerpt chronicles how Nygard allegedly used his power and privilege to take advantage of people.

Much of the alleged illegal activity is said to have taken place in and around Nygards 150,000-square-foot estate in Lyford Cay, Bahamas, which featured fake volcanos spouting dry ice, a gym on the beach, statues of nudes supposedly modeled on Nygards exes, a disco hut with cameras under the floors, an underground Mayan-themed cave housing 30 cars and an indoor swimming pool with glass through the middle, which allegedly had dolphins on one side and sharks on the other.

Massive cauldrons come to life, blazing with flames. The eyes of concrete Mayan-style gargoyles and snakes glow like embers. Angry organ chords in a minor key shoot out across the ocean, the beach and the surrounding properties: the foreboding first notes of the theme to Andrew Lloyd Webbers Phantom of the Opera.

When Peter Nygard was in residence at Nygard Cay, neighbors say, that was the nightly soundtrack. In the booming early 2000s, Nygard Cay was a playground for lingerie and bikini models flown in from Las Vegas and other major US cities.

According to Nygards [house manager], Richette Ross, his staffers used Facebook posts and messages to promote upcoming parties, which offered free dinners, massages, pedicures, and boat rides to guestsmainly females, said Ross. Mr. Nygard didnt like the competition.

Once the party began, though, Nygard would kick off a twisted competition of his own, she claimed. As guests arrived, they would be photographed and entered into Nygards personal database. He even rated them upon entry, Ross claimed: A, B, C or D, with A being the most beautiful. Ross claimed [those] women had to have what Nygard called a nice toilet a nice ass. It had to be big and round.

Ross claimed, Throughout the day, hed ask a particular girl if shed like to stay the night. If she said no? Ross alleged, Then theres always drugging.

Ross said that she personally witnessed one of Nygards bartenders drop a pill into a girls drink.

Around 10:00, we were almost ready to shut down, Ross claimed, when she spotted the girl again. She was crying naked in the office. Disorientated.

Tragically, according to Ross, this wasnt an unusual occurrence. She claimed, It happened often. She even said that at least once, she saw a girl escape from the property, only to be brought back by Bahamian police, apparently against her will.

When the New York Times covered the sexual assault accusations against Nygard earlier this year, it revealed that two accusers interviewed had then recanted and said they had been paid to lie by Ross. (Nygard has also claimed that his billionaire neighbor, Louis Bacon, with whom hes feuded for years, has paid people to make false statements about him.) However, Ross denied having paid anyone to lie and passed a polygraph test supporting her denial. In the book, Ross alleges that she herself even fell prey to her boss wicked scheme

Nygards girlfriend offered [Ross] a glass of wine. It seemed unusual, and she declined the offer to focus on her work. Still, Ross said, She stopped me and insisted I have that glass of wine. As I was going up the stairs I felt a warmness coming over my body. I turned to tell [Nygard] I wasnt feeling good. I remember going down.

When I came to, Ross alleged, he was penetrating me. I could see from the mirror (on the ceiling). I knew he was on top of me. I remember trying to ease my way to the edge of the bed He raped me.

Ross finally quit working for Nygard in 2014. She found support in a local nonprofit organization founded to help sexual violence victims. Ross even became a sort of leader in the community, introducing other alleged victims to the organization in the hopes of getting them therapy and the community support theyd never had.

She even has alleged that Nygard went so far as to kill her family dog. The New York Times found that Nygard actually wired her $10,000 at one point, emailing Ross: I sent you money to buy a new dog. (He blamed the dogs death on a political rival.)Before long, though, Ross had made herself a target. At one point, I was basically in hiding, she alleged, describing threats that were issued all the time.

According to the book, Nygard had almost unlimited power to do what he wanted in the Bahamas after bribing officials from the governments Progressive Liberal Party.

Former Nygard employee Richette Ross said she was personally tasked with putting together payoffs for high-ranking [Progressive Liberal Party] members.

[She claimed to have seen] stacks of $10,000 bundles from the bank stuffed into bags for delivery. For some, Ross said even that method of handoff was too risky. She claimed that Nygard got creative in his efforts to pay off politicos.

Mr. Nygard had required that I order some very large fish, she said. He had about $100,000 in $10,000 bundles. He told me he wanted me to break them up, roll them, and put them in this fish.

According to records obtained by the Bahamas Tribune, Shane Gibson [a member of the PLP] received $94,131.10 deposited into his Miami bank account from the Nygard Companies in 2012 and 2013. The donations were usually $5,000 or more, and were deposited on a semi-regular basis, marked services or travel.

When confronted with the records, Gibson, the Minister of Immigration and Labor at the time, told the Tribune that they were campaign donations, as well as financial contributions to community programs he was spearheading, like scholarships for local students. Gibson would later be photographed at one of Nygards pamper parties in 2014. (Gibson did not respond to The Posts requests for comment.) With Nygards support, the PLP rolled to victory in 2012 and the designer was quick to claim credit.

According to court documents obtained by the Tribune newspaper shortly [after the election] the government determined that appropriate acreage should be leased to Mr. Peter Nygard so he could develop a stem cell facility as a part of what was termed a touristic development.

Nygard admitted to having [met with government officials], but his attorneys later claimed that the minutes of that meeting had been fabricated, and that he had no desire to curry preferential treatment by the Bahamian government. The campaign to get his stem cell mecca built, though, would consume him for the next several years.

Nygard, obsessed with staying young, ended up establishing his stem cell research company in nearby St. Kitts. The alleged purpose: to use aborted fetuses from his pregnant girlfriends to provide him with fresh stem cells.

Nygard seemed to suggest that something like that could be afoot when he talked about the technology behind his treatments publicly. I may be the only person in the world, he bragged, who has my own embryos growing in a petri dish.

When I came to he was on top of me. I remember trying to ease my way to the edge of the bed.

Peter Nygards former house manager Richette Ross, claiming in Predator King that he drugged and raped her

One of his girlfriends, Suelyn Medeiros, wrote in her 2014 memoir about a trip she took with Nygard to Ukraine, where he was having stem cell research done.

He asked, Suelyn, do you know what the best stem cells are? she writes.

She did: Embryos.

Correct! she says Nygard responded. If you got pregnant and had an abortion, we could use those embryonic cells and have a lifes supply for all of us: you, your mother and me. A lot of people are doing it.

Medeiros says she was beyond stunned.

This was the sickest thing Id ever heard Peter say, she writes. I couldnt speak for a moment Finally, catching my breath, I said, Peter, I do not believe in abortion.

On Feb. 13, 2020, a class-action complaint on behalf of several Jane Does was filed in the US District Court for the Southern District of New York and revealed Nygards depravation.

On so many nights, it was alleged, the same story would unfold: Nygard lures the victims to his bedroom or has them ushered there by groomers, under the false pretense of discussing a potential modeling contract in private, where he uses physical force or coercion or knowing the victim has not attained the age of 18 years, to engage in commercial sex acts and coerce and force them to engage in unwanted sexual acts

The amounts of money provided to the victims is more than most of [them] have seen at one time in their entire lifetimes He promises many victims that he will contact them about future modeling contracts. However, in the vast majority of cases, Nygard never intends to follow through with the modeling contracts and tells his victims this for the sole purpose of maintaining control over them.

[He] also threatens the victims with implied or express threats of retribution if they tell anyone about what happened, often implying or expressly threatening to have his victims killed if they do not cooperate.

Today, Nygards Lyford Cay estate is quiet no more Phantom of the Opera melodies after it was seized by local authorities in 2018 because of illegal dredging, according to Canadas National Post. The moguls company filed for Chapter 15 bankruptcy in New York last week, and Nygard is reportedly in Winnipeg, Manitoba, awaiting the outcome of the FBI investigation.

The rest is here:
Inside the twisted world of 'rapist' designer Peter Nygard: book - The Loppy

Induced Pluripotent Stem Cells Market Latest Trends and Analysis Future Growth Study by 2029 Cole Reports – Cole of Duty

Induced pluripotent stem cells (iPSCs) hold profound potential in replacing the use of embryonic stem cells (ESCs) as important tool for drug discovery and development, disease modeling, and transplantation medicine. Advent of new approaches in reprogramming of somatic cells to produce iPSCs have considerably advanced stem cell research, and hence the induced pluripotent stem cells market. The iPSC technology has shown potential for disease modeling and gene therapy in various areas of regenerative medicine. Notable candidates are Parkinsons disease, spinal cord trauma, myocardial infarction, diabetes, leukemia, and heart ailments.

Get Sample Copy of the Report @https://www.tmrresearch.com/sample/sample?flag=B&rep_id=6245

Over the past few years, researchers have come out with several clinically important changes in reprogramming process; a case in point is silencing retroviruses in the human genome. Molecular mechanisms that underlie reprogramming have gained better understanding. However, the tools based on this growing understanding are still in nascent stage. Several factors affect the efficiency of reprogramming, most notably chromosomal instability and tumor expression. These have hindered researchers to utilize the full therapeutic potential of iPSCs, reflecting an unmet need, and hence, a vast potential in the induced pluripotent stemcellsmarket.

The growing application of induced pluripotent stem cells in generating patient-specific stem cells for drug development and human disease models is a key dynamic shaping their demands. Growing focus on personalized regenerative cell therapies among medical researchers and healthcare proponents in various countries have catalyzed their scope of induced pluripotent stem cells market. Advent of new methods to induce safe reprogramming of cells have helped biotechnology companies improve the clinical safety and efficacy of the prevailing stem cells therapies. The relentless pursuit of alternative source of cell types for regenerative therapies has led industry players and the research fraternity to pin hopes on iPSCs to generate potentially a wide range of human cell types with therapeutic potential.

Request TOC of the Report @https://www.tmrresearch.com/sample/sample?flag=T&rep_id=6245

Advances pertaining to better utilizing of retrovirus and lentivirus as reprogramming transcription factors in recent years have expanded the avenue for players in the induced pluripotent stem cells market. Increasing focus on decreasing the clinical difference between ESCs and iPSCs in all its entirety has shaped current research in iPSC technologies, thus unlocking new, exciting potential for biotechnology and pharmaceutical industries.

Over the past few years, fast emerging markets in the global induced pluripotent stem cells are seeing the advent of patents that unveil new techniques for reprogramming of adult cells to reach embryonic stage. Particularly, the idea that these pluripotent stem cells can be made to form any cells in the body has galvanized companies to test their potential in human cell lines. Also, a few biotech companies have intensified their research efforts to improve the safety of and reduce the risk of genetic aberrations in their approved human cell lines. Recently, this has seen the form of collaborative efforts among them.

Lineage Cell Therapeutics and AgeX Therapeutics have in December 2019 announced that they have applied for a patent for a new method for generating iPSCs. These are based on NIH-approved human cell lines, and have been undergoing clinical-stage programs in the treatment of dry macular degeneration and spinal cord injuries. The companies claim to include multiple techniques for reprogramming of animal somatic cells.

Such initiatives by biotech companies are expected to impart a solid push to the evolution of the induced pluripotent stem cells.

North America is one of the regions attracting colossal research funding and industry investments in induced pluripotent stem cells technologies. Continuous efforts of players to generate immune-matched supply of pluripotent cells to be used in disease modelling has been a key accelerator for growth. Meanwhile, Asia Pacific has also been showing a promising potential in the expansion of the prospects of the market. The rising number of programs for expanding stem cell-based therapy is opening new avenues in the market.

Get Discount on Latest Report @https://www.tmrresearch.com/sample/sample?flag=D&rep_id=6245

About TMR Research:

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in todays supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:

TMR Research,3739 Balboa St # 1097,San Francisco, CA 94121United StatesTel: +1-415-520-1050

Read more here:
Induced Pluripotent Stem Cells Market Latest Trends and Analysis Future Growth Study by 2029 Cole Reports - Cole of Duty

Global Zinc Finger Nuclease Technology Market to Generate Lucrative Revenue Prospects for Manufacturers After the End of COVID-19 Crisis and Forecast…

Nucleases are the enzyme, used to cleave DNA into smaller units. Zinc-finger (ZFN) nucleases are artificial restriction enzyme used to cleave DNA into smaller fragments. It is the class of engineered DNA-binding proteins that creates double standard break at specified locations. It consist of two functional domain, a DNA-binding domain, and a DNA-cleaving domain. DNA binding domain recognizes the unique hexamer sequence of DNA and DNA-cleaving domain consisting nuclease domain of Fok I. The fusion between the DNA-binding domain, and a DNA-cleaving domain creates artificial restriction enzyme known as molecular scissor that cleaves the desired DNA sequence. ZFN is based on the DNA repair machinery and is becoming a prominent tool in the field of genome editing.

Request to Sample report @ https://www.persistencemarketresearch.com/samples/16615

Zinc finger nucleases are useful for various biotechnological and life science applications. It is used to manipulate plants and animals for research purpose and is used in the clinical trial of CD4+ human T-cells for the treatment of AIDS. It is also used in the generation of disease model known as isogenic human disease model. The therapeutic approach involving ZFNs is associated with the problems related to viral gene delivery, ex vivo therapy involving own stem cells. Some of the disadvantages of the zinc finger nuclease technology is that sometimes cannot target the specific site, within the gene of interest and creates many double standard break and yield chromosomal rearrangements, which can lead to cell death and risk of immunological response against the therapeutic agent.

The rise in the incidence of chronic diseases such as cardiovascular diseases, cancer, blood pressure, obesity and others due to sedentary lifestyle has led to the excessive research and development for the development of new therapeutic agent to treat various disease condition. Benefits of Zinc Finger Nuclease (ZFN) includes permanent and heritable mutations, are effective for the variety of mammalian somatic cell types, single transfection is enough to induce editing in gene, antibiotic screening is not required for selection. These benefits has helped researched to carry out their research process easily with limited accessories.

Zinc finger nuclease will be the core technology for biotechnology companies in coming years due to its wide applications such as cell screening, cell based optimization, target validation, functional genome editing to produce higher yield of target proteins, antibodies and others. Well- established, robust protocol using zinc finger nuclease technology will deliver accurate results and boost the market of zinc finger nuclease technology in the near future.

Request PMR insights on measuring the impact of COVID-19 coronavirus across industries.

The global market zinc finger nuclease technology is segmented on basis of application, end user and geography:

Segment by Application

Segment by End User

The global market for zinc finger nuclease technology is segmented into application type and end user. Based on the application type, the zinc finger nuclease market is segmented into cell line engineering, animal genetic engineering, plant genetic engineering, Based on the end user, the market is segmented into biotechnology industry, pharmaceutical company, hospital and diagnostic laboratory, academic and research institutes. Due to technological advantage of ZFN technology over other genome editing technologies, high precision, specificity, and efficacy of the zinc finger technology has projected to the growth of the zinc finger technology market in the near future

By regional presence, the global zinc finger nuclease technology market is segmented into five broad regions viz. North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. North America is estimated to account for major share followed by European countries. Mainly the U.S. & European markets, owing to its innate nature of developed healthcare infrastructure, adopts advanced technology at early stage as compared to developing economies, high pricing of drugs/medical devices/technology, increase in incidence of lifestyle diseases, that follows large patient pool etc. is estimated to maintain its leadership geographically . Significant economic development has led to an increase in healthcare availability in Asia Pacific region, growing number of research institutes, laboratories, investment in research and development and penetration of global players in Asia is expected to fuel demand for gene editing technologies such as zinc finger nuclease technology for research and development, advancement in the diagnostic and treatment process.

Request to View TOC @ https://www.persistencemarketresearch.com/toc/16615

Some of the major players in zinc finger nuclease technology are ,

Sigma-Aldrich Co. LLC is a part of Merck Inc. and operated life science business and has reached various geographies to fulfill customer needs. Sangamo Therapeutics, Inc. has developed range of gene editing technologies with therapeutic approach. Many life sciences company and large pharmaceutical company are collaborating to develop and commercialize gene editing technologies to introduce advanced life science products.

For in-depth competitive analysis, buy [emailprotected] https://www.persistencemarketresearch.com/checkout/16615

Read this article:
Global Zinc Finger Nuclease Technology Market to Generate Lucrative Revenue Prospects for Manufacturers After the End of COVID-19 Crisis and Forecast...

Global Stem Cell Media Market Competitive Dynamics and Industry Outlook 2025 – Cole of Duty

Report Summary:,The global Stem Cell Media market report is a comprehensive study that encompasses top manufacturers, prospective market share, revenue, purchaser volume with respect to dealing volume and global segmentation for the Stem Cell Media industry. The report further includes market classification and definitions, product and industry overview, manufacturing specifications and cost structure, included raw materials and so on.

In addition to the vast definitive data, the report also sheds light on the past behavior of the market and an upcoming growth graph that is expected to venture in an upwards trajectory despite market fluctuations and trends.

Request a sample of Stem Cell Media Market report @ https://hongchunresearch.com/request-a-sample/1640

Market Segmentation:,The Stem Cell Media report follows an accumulated research methodology that is based on years of experience combined with structured data points acquired from proprietary sources. These methods function with thorough research and analysis split between primary and secondary research combined with an in-house data wrangling process. In general, the data points are gathered from a variety of sources such as vendor projections, product list, research papers and a detailed list of manufacturers. The analysis is than derived into quantitative market values such as qualitative and quantitative qualities, market forecast models, market segmentations and business models that revolve around the Stem Cell Media industry.

Moreover, the Stem Cell Media market report clarifies the market segmentation based on various parameters and attributes that can be classified on geographical region, product types and market applications.

The report provides a comprehensive analysis of the Stem Cell Media industry market by types, applications, players and regions. This report also displays the production, Consumption, revenue, Gross margin, Cost, Gross, market share, CAGR, and Market influencing factors of the Stem Cell Media industry in USA, EU, China,India, Japan and other regions, and forecast to 2025, from 2019.

Market Analysis by Players,Thermo Fisher,STEMCELL Technologies,Merck Millipore,Lonza,GE Healthcare,Miltenyi Biotec,Corning,CellGenix,Takara,PromoCell

Market Analysis by Regions:,USA,Europe,Japan,China,India,Southeast Asia,South America,South Africa,Others

Market Analysis by Types:,Pluripotent Stem Cell Culture,Hematopoietic Stem Cell Culture,Mesenchymal Stem Cell Culture,Others

Market Analysis by Applications:,Scientific Research,Industrial Production

The report also focuses on developing market trends, preferred market channels and market drivers & restraints to name a few.

Major Point of TOC:

Chapter One: Stem Cell Media Market Overview

Chapter Two: Global Stem Cell Media Competitions by Players

Chapter Three: Global Stem Cell Media Competitions by Types

Check [emailprotected] https://hongchunresearch.com/check-discount/1640

Chapter Four: Global Stem Cell Media Competitions by Application

Chapter Five: Global Stem Cell Media Production Market Analysis by Region

Chapter Six: Global Stem Cell Media Sales Market Analysis by Region

Chapter Seven: Imports and Exports Market Analysis

Chapter Eight: Global Stem Cell Media Players Profiles and Sales Data

Chapter Nine: Stem Cell Media Upstream and Downstream Analysis

Chapter Ten: Global Stem Cell Media Market Forecast (2017-2022)

Chapter Eleven: Research Findings and Conclusion, Continue

About HongChun Research:HongChun Research main aim is to assist our clients in order to give a detailed perspective on the current market trends and build long-lasting connections with our clientele. Our studies are designed to provide solid quantitative facts combined with strategic industrial insights that are acquired from proprietary sources and an in-house model.

Contact Details:Jennifer GrayManager Global Sales+ 852 8170 0792[emailprotected]

NOTE: Our report does take into account the impact of coronavirus pandemic and dedicates qualitative as well as quantitative sections of information within the report that emphasizes the impact of COVID-19.

As this pandemic is ongoing and leading to dynamic shifts in stocks and businesses worldwide, we take into account the current condition and forecast the market data taking into consideration the micro and macroeconomic factors that will be affected by the pandemic.

Go here to read the rest:
Global Stem Cell Media Market Competitive Dynamics and Industry Outlook 2025 - Cole of Duty

Global Covid-19 impact on Stem Cell Source Market : How much will be the total production? – Cole of Duty

Global Stem Cell Source Market Research Report estimates the size of the market for 2020 and projects its growth by 2025. It provides a detailed qualitative and quantitative analysis of the Global Stem Cell Source market. And collect useful data for this extensive, commercial study of the Global Stem Cell Source market. The global Global Stem Cell Source report is a basic hold of information, essentially for the business executives.

Development policies and plans are discussed as well as manufacturing processes and industry chain structure is analyzed. This report also states import/export, supply and consumption figures as well as manufacturing cost, global revenue and presents gross margin by regions like North America, Europe, Japan, China and other countries (India, Southeast Asia, Central & South America, Middle East & Africa etc.)

Leading players of the global Stem Cell Source market are analyzed taking into account their market share, recent developments, new product launches, partnerships, mergers or acquisitions, and markets served. We also provide an exhaustive analysis of their product portfolios to explore the products and applications they concentrate on when operating in the global Stem Cell Source market. Furthermore, the report offers two separate market forecasts one for the production side and another for the consumption side of the global Stem Cell Source market. It also provides useful recommendations for new as well as established players of the global Stem Cell Source market.

Request for Sample Copy of This Report @https://www.reporthive.com/request_sample/2288513

Key Companies Analyzed in this Report are:

BD BioscienceBeckman CoulterGe HealthcareMerck MilliporeMiltenyi BiotecPluriselect Life ScienceSigma-Aldrich CorporationStemcell TechnologiesTerumo BCTThermo Fisher ScientificCompany 13

Market segment by Type, the product can be split into

ReagentInstrumentOthers

Market segment by Application, split into

HospitalBiotechnology Research CenterOthers

The report forecast global Stem Cell Source market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2020-2025.The report offers detailed coverage of Stem Cell Source industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Stem Cell Source by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

The report offers in-depth assessment of the growth and other aspects of the Stem Cell Source market in important countries (regions), including:

North America(United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

The report forecast global Stem Cell Source market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2020-2025.The report offers detailed coverage of Stem Cell Source industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Stem Cell Source by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

Market segmentation

Stem Cell Source market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

For Customised Template PDF Report:https://www.reporthive.com/request_customization/2288513

The report also covers competitive developments, such as long-term contracts, new product launches and developments, and research & development activities being carried out various leading players such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information in this market. It also provides information regarding various business and corporate strategies adopted by key players to strengthen their position in this market. In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Global Stem Cell Source Market: Competitive RivalryThe chapter on company profiles studies the various companies operating in the global Stem Cell Source market. It evaluates the financial outlooks of these companies, their research and development statuses, and their expansion strategies for the coming years. Analysts have also provided a detailed list of the strategic initiatives taken by the Stem Cell Source market participants in the past few years to remain ahead of the competition.

Table of Contents

Report Overview:It includes major players of the global Stem Cell Source market covered in the research study, research scope, and Market segments by type, market segments by application, years considered for the research study, and objectives of the report.

Global Growth Trends:This section focuses on industry trends where market drivers and top market trends are shed light upon. It also provides growth rates of key producers operating in the global Stem Cell Source market. Furthermore, it offers production and capacity analysis where marketing pricing trends, capacity, production, and production value of the global Stem Cell Source market are discussed.

Market Share by Manufacturers:Here, the report provides details about revenue by manufacturers, production and capacity by manufacturers, price by manufacturers, expansion plans, mergers and acquisitions, and products, market entry dates, distribution, and market areas of key manufacturers.

Market Size by Type:This section concentrates on product type segments where production value market share, price, and production market share by product type are discussed.

Market Size by Application:Besides an overview of the global Stem Cell Source market by application, it gives a study on the consumption in the global Stem Cell Source market by application.

Production by Region:Here, the production value growth rate, production growth rate, import and export, and key players of each regional market are provided.

Consumption by Region:This section provides information on the consumption in each regional market studied in the report. The consumption is discussed on the basis of country, application, and product type.

Company Profiles:Almost all leading players of the global Stem Cell Source market are profiled in this section. The analysts have provided information about their recent developments in the global Stem Cell Source market, products, revenue, production, business, and company.

Market Forecast by Production:The production and production value forecasts included in this section are for the global Stem Cell Source market as well as for key regional markets.

Market Forecast by Consumption:The consumption and consumption value forecasts included in this section are for the global Stem Cell Source market as well as for key regional markets.

Value Chain and Sales Analysis:It deeply analyzes customers, distributors, sales channels, and value chain of the global Stem Cell Source market.

Key Findings: This section gives a quick look at important findings of the research study.

About Us:Report Hive Research delivers strategic market research reports, statistical surveys, industry analysis and forecast data on products and services, markets and companies. Our clientele ranges mix of global business leaders, government organizations, SMEs, individuals and Start-ups, top management consulting firms, universities, etc. Our library of 700,000 + reports targets high growth emerging markets in the USA, Europe Middle East, Africa, Asia Pacific covering industries like IT, Telecom, Semiconductor, Chemical, Healthcare, Pharmaceutical, Energy and Power, Manufacturing, Automotive and Transportation, Food and Beverages, etc. This large collection of insightful reports assists clients to stay ahead of time and competition. We help in business decision-making on aspects such as market entry strategies, market sizing, market share analysis, sales and revenue, technology trends, competitive analysis, product portfolio, and application analysis, etc.

Contact Us:

Report Hive Research

500, North Michigan Avenue,

Suite 6014,

Chicago, IL 60611,

United States

Website: https://www.reporthive.com

Email: [emailprotected]

Phone: +1 312-604-7084

See the article here:
Global Covid-19 impact on Stem Cell Source Market : How much will be the total production? - Cole of Duty

COVID-19 Patients With Cancer in New York City Have a High Death Rate – Cancer Health Treatment News

COVID-19 patients with cancer appear to have a higher rate of death than those without cancer, but the risk varies widely by cancer type, according recent study by researchers at Montefiore Health System in the Bronx in the New York City, the epicenter of the coronavirus epidemic in the United States.

Our findings emphasize the need to prevent cancer patients from contracting COVID-19 andif they doto identify and closely monitor these individuals for dangerous symptoms, lead study author Vikas Mehta, MD, MPH, of Montefiore Health System and Albert Einstein Medical College said in a press release. We hope that our findings can inform states and communities that have not yet been so severely struck by this pandemic about the unique vulnerability cancer patients face.

The latest results were published May 1 in the American Association for Cancer Research (AACR) journal Cancer Discovery. Earlier in the week, the AACRs virtual annual meeting featured a special session on COVID-19 and cancer, which included reports of outcomes among cancer patients with COVID-19 in China, Italy, France and Spain. Louis Voight, MD, of Memorial Sloan Kettering Cancer Center in New York City, gave an overview of COVID-19 in the United States, with a focus on racial and ethnic disparities, but that talk did not include detailed patient outcome findings.

Early reports from China, where the coronavirus pandemic originated in late December, showed that older people, those with compromised immune systems and those with underlying health conditions are more susceptible to severe COVID-19. One study saw a death rate of 6% for people with cancermore than twice as high as the overall COVID-19 mortality rate in China.

There are several reasons why people with cancer might be at greater risk. Many are older and have coexisting health conditions. Chemotherapy medications and some targeted therapies for cancer can cause neutropenia, a temporary depletion of immune system white blood cells that fight infection. People who receive bone marrow stem cell transplants or CAR-T therapy or for blood cancers are at especially high risk.

Vikas Mehta, MD, of Albert Einstein Medical College in New York City, and colleagues identified 218 COVID-19 patients with cancer, mostly from the Bronx, treated in the Montefiore Health System between March 18 and April 8, 2020. Many had been exposed to the coronavirus in healthcare settings, including nursing homes and hospitals. Three quarters had solid tumors and a quarter had blood cancers. Most were not currently on cancer treatment.

Of these, 61 (28%) died of COVID-19. Mortality rates were 37% for those with blood cancers and 25% for those with any solid tumor. People with blood cancers were also more likely to be admitted to the ICU (26% versus 19%, respectively), but about equally likely to be put on a ventilator (11% versus 10%).

Severe lung damage in people with COVID-19 may be caused by an overactive immune response known as a cytokine storm, in which the immune system goes into overdrive and releases large amounts of chemical messengers such as interleukin 6 (IL-6). The study authors suggested that people with blood cancers may be more susceptible to cytokine-mediated inflammation due to disruption of various types of immune cells. Researchers are now testing whether the IL-6 blocker Actemra (tocilizumab)a medication used to treat immune-mediated side effects in people receiving checkpoint inhibitors or CAR-T therapycan prevent or calm the cytokine storm in people with COVID-19.

Looking at the solid tumors, people with pancreatic cancer (67%), lung cancer (55%), and colorectal or gynecological malignancies (both 38%) had elevated death rates, while those with prostate cancer (20%) or breast cancer (14%) had lower mortality. People with advanced metastatic cancer had a trend toward higher mortality, but this did not reach statistical significance.

Comparing these numbers against death rates among people of the same age without cancer in the same health system and in the city as a whole, the researchers concluded, Cancer patients demonstrate a markedly increased COVID-19 mortality rate compared to non-cancer and all New York City COVID-19 patients. In fact, case fatality rates were two to three times higher among people with cancer compared to those without cancer.

The researchers acknowledged that socioeconomic disparities affecting people in the Bronx might contribute to the high death rates seen in this study. Black people, in particular, are increasingly recognized as having worse COVID-19 outcomes, accounting for 33% of all hospital admissions while making up just 13% of the U.S. population. But in this analysis, the racial/ethnic distribution of COVID-19 patients reflected that of the surrounding community.

In this analysis, current chemotherapy or radiation therapy were not linked to increased mortality, unlike the associations seen in some other cancer and COVID-19 studies. Very few patients were on immunotherapy, and it also did not show an association with mortality.

A key element is that mortality appears to be more closely related to frailty, age and co-morbidities than to active therapy for cancer, said Balazs Halmos, MD, of Albert Einstein Medical College, one of the senior authors.

Our data suggest that we should not stop lifesaving cancer therapies, but rather develop strategies to minimize potential COVID-19 exposures and re-evaluate therapies for our most vulnerable cancer populations, added co-senior authorAmit Verma, MBBS, also from Einstein.

Click here to read the study abstract.Learn about What People With Cancer Need to Know About the New Coronavirus.

Read more from the original source:
COVID-19 Patients With Cancer in New York City Have a High Death Rate - Cancer Health Treatment News

Profitable Trending Report on Stem Cell Cartilage Regeneration Market by 2020 to 2027 With Key Players: Anika Therapeutics, Zimmer Biomet, BioTissue…

The Stem Cell Cartilage Regeneration Market (2020) research report explores the market in terms of Revenu, Emerging Market Trends and Driver includes up to date analysis and forecasts for various market segments, major players, and all geographical regions till 2027.

The coronavirus epidemic (COVID-19) has affected all aspects of life around the world. This has changed some of the market situation. The main purpose of the research report is to provide users with a broad view of the market. Initial and future assessments of rapidly changing market scenarios and their impact are covered in the report. The report will account for Covid19 as a key market contributor.

The top players covered in Stem Cell Cartilage Regeneration Market are: Anika Therapeutics, Zimmer Biomet, BioTissue Technologies, DePuy (Johnson & Johnson), Genzyme, CellGenix, EMD Serono, Sanofi Aventis, Smith & Nephew

Download Sample PDF PagesClick Here!

This report sample includes: Brief Introduction to the research report, Table of Contents (Scope covered as a part of the study), Top players in the market, Research framework (presentation), Research methodology adopted by Worldwide Market Reports

Stem Cell Cartilage Regeneration Market Outlook:

Global Stem Cell Cartilage Regeneration market report provides exclusive coverage that has been provided for market drivers and challenges & opportunities for a country-level market in the respective regional segments. The report comprises a competitive analysis of the key players functioning in the market and covers in-depth data related to the competitive landscape of the market and the recent strategies & products that will assist or affect the market in the coming years.

Market Drivers and the Risks Associated with the Stem Cell Cartilage Regeneration Market:

The international Stem Cell Cartilage Regeneration market has been characterized by several primary factors, with each factor tends of playing a crucial role in the boom of the market. The growth in the products has doubled with the smoother availability of the customer base that has been helping the company of flourishing globally. On the other hand, the presence of a dynamic supply chain has helped the company to grow exponentially. Therefore, regarding the increase in the opportunities of the market Stem Cell Cartilage Regeneration faces severe complaints from all the aspects.

Enumerating some of the fundamental parameters encompassed in the report:

Major Geographical Regions and Market of the Stem Cell Cartilage Regeneration Market:

When a better look taken at the areas, the market has concentrated, and the file interior the important makes a strong point of Europe, Middle East & Africa, Asia Pacific, Latin America, and North America. These areas have studied regarding the hooked-up traits and the diverse possibilities in addition to the outlook that allows inside the benefitting of the market ultimately.

Buy This Complete Business Report: Access Insightful Study With Over 100+ Pages, List of Tables and Figures, Profiling 10+ Companies Click Here!

Stem Cell Cartilage Regeneration Market Report Covers Following Questions:

Customization Service of the Report: Place Query: Click Here!

Worldwide Market Reports provides customization of reports as per your request. This report can be personalized to meet your requirements. Get in touch with our research team, who will make sure you get a report that suits your necessities.

Continued here:
Profitable Trending Report on Stem Cell Cartilage Regeneration Market by 2020 to 2027 With Key Players: Anika Therapeutics, Zimmer Biomet, BioTissue...

Wilson to receive Norton Medal – UB Now: News and views for UB faculty and staff – University at Buffalo Reporter

Campus News

The Chancellor Charles P. Norton Medal is UB's highest honor. Photo: Douglas Levere

UBNOW STAFF

Mary Wilson, wife of the late Buffalo Bills owner Ralph Wilson and a strong advocate of Western New York for the past 29 years, will be awarded the Chancellor Charles P. Norton Medal, UBs highest honor.

Jean Wactawski-Wende, SUNY Distinguished Professor of Epidemiology, dean of the School of Public Health and Health Professionals, and an internationally recognized researcher on womens health issues, will receive the UB Presidents Medal in recognition of extraordinary service to the university.

SUNY honorary doctorates are being presented to UB alumna Donnica L. Moore, president of the Sapphire Womens Health Group, and Richard A. Schatz, research director of cardiovascular interventions at the Scripps Heart, Lung and Vascular Center.

Wactawski-Wende will receive the Presidents Medal during the School of Public Health and Health Professions virtual commencement ceremony on May 16; the other award recipients will receive their honors at a later date.

The Chancellor Charles P. Norton Medal is presented annually in public recognition of a person who has, in Nortons words, performed some great thing which is identified with Buffalo a great civic or political act, a great book, a great work of art, a great scientific achievement or any other thing which, in itself, is truly great and ennobling, and which dignifies the performer and Buffalo in the eyes of the world.

Announcing this years Norton Medal recipient, Jeremy M. Jacobs, chair of the UB Council, said that Mary Wilson richly deserves the honor for her longstanding commitment to the region.

This year, we were absolutely unanimous in our decision to honor Mary Wilson, he said. In her leadership of the Wilson Foundation, Mary is making an enduring and unprecedented impact on Buffalo and all of Western New York, which will be felt for many generations to come. Her dedication and work align perfectly with the spirit of the Norton Medal.

Wilson has been devoted to Western New York since she first arrived in the area for the Bills home opener in 1990. She has spent many years developing her Western New York Girls in Sports program, which biannually brings more than 200 9- to 12-year-old girls together to take part in various sports taught by young athletes from local universities and sports clubs. The program, now ensured to run in perpetuity, is organized by the United Way of Buffalo and Erie County through an endowment from the Ralph C. Wilson Jr. Foundation, of which Wilson serves as one of four life trustees.

She has also supported organizations benefiting communities in Buffalo, Erie County and Southeast Michigan, among them Hospice of Western New York, WNY Womens Foundation, Food Bank of Western New York, Albright-Knox Art Gallery, Girl Scouts of Western New York, the SPCA serving Erie County, the Buffalo Philharmonic Orchestra, the Alzheimers Association Greater Michigan Chapter, The Helm (formerly Services for Older Citizens), the Detroit Symphony Orchestra, the Detroit Historical Society and the Detroit Institute of Arts, to name a few.

The UB Presidents Medal, first presented in 1990, recognizes outstanding scholarly or artistic achievements, humanitarian acts, contributions of time or treasure, exemplary leadership or any other major contribution to the development of the University at Buffalo and the quality of life in the UB community.

President Satish K. Tripathi described recipient Jean Wactawski-Wende as a world-renowned epidemiologist who has brought great prominence to UB through her scholarly pursuits and academic excellence in the area of womens health.

A dedicated member of our university community for more than 30 years, Dr. Wactawski-Wende has made seminal contributions that have significantly impacted health care practice and disease prevention for women in the U.S. and around the world, he said.

Thanks to her tremendous leadership, she has further elevated the reputation of UB. Our university community, along with the many communities we serve, have been profoundly enriched by Dr. Wactawski-Wendes scholarship, teaching and service, and it is an honor to present the Presidents Medal to such a truly deserving recipient.

Of particular note is Wactawski-Wendes leadership role in the Womens Health Initiative (WHI), the largest longitudinal study of womens health in the United States. In 1993, she was part of the team that spearheaded UBs successful bid to become one of the federally funded studys 16 original vanguard clinical centers. Since the inception of the WHI, UB has received more than $30 million in funding from the National Institutes of Health to investigate health issues impacting postmenopausal women.

Among the WHIs major discoveries was the groundbreaking finding that intake of combined estrogen plus progestin was associated with an increased risk of heart disease, stroke and invasive breast cancer. That research, on which Wactawski-Wende served as a co-principal investigator, changed the use of hormone therapy in older women worldwide, potentially saving countless lives.

Through UBs current $6.2 million award extension of the WHI, she has overseen the continuation of research into many diseases associated with aging, such as cardiovascular disease, cancer, osteoporosis, stroke and dementia. She is also administering new studies that focus on frailty and predictors of healthy aging.

For those of us who know and have worked closely with Dr. Wactawski-Wende, we readily recognize the magnitude and excellence of her contributions to academic medicine, said Michael E. Cain, vice president for health sciences and dean of the Jacobs School of Medicine and Biomedical Sciences at UB. She is an eminent and distinguished scholar and leader whose work, professional service, and stature in her discipline and research field are outstanding and continue to grow.

An internationally recognized womens health expert and advocate, Donnica L. Moore is president of Sapphire Womens Health Group, a multimedia firm that educates women about the benefits of a healthy lifestyle. A pioneering physician, Moore utilizes public speaking and multiple media platforms including her own website and podcast to share impactful health information in laypersons terms.

She will receive a SUNY Honorary Doctorate in Science.

Dr. Moores significant accomplishments associated with women's health set an inspiring example for our university community and reflect the values of both UB and the SUNY system, Tripathi said.

Breaking barriers to educate women about an array of health-related topics, she has demonstrated a sustained and dedicated commitment to the well-being of women around the globe. One of UBs most distinguished alumni, Dr. Moore in utilizing accessible platforms to create broad access to sound, peer-reviewed medical information is enhancing lives in communities near and far.

A 1986 alumna of the Jacobs School of Medicine and Biomedical Sciences, Moore underwent residency training in obstetrics and gynecology at Temple University, followed by a year of family medicine training at Memorial Hospital of Burlington, New Jersey. The editor-in-chief of Womens Health for Life, she has served on the editorial boards of the Journal of Women's Health and the Journal of the American Medical Womens Association, in addition to the board of directors of the Society for Womens Health Research, among other organizations.

Known for her relatable delivery and depth of expertise, Moore was the womens health contributor for NBCs Later Today and has appeared more than 800 times on such programs as The Oprah Winfrey Show, The Anderson Cooper Show and Good Morning America. Additionally, she has been a medical adviser or medical advisory board member for companies including DuPont and Helm Pharmaceuticals.

Richard A. Schatz is co-creator of the first coronary stent approved by the Food and Drug Administration for restenosis. Known as the Palmaz-Schatz stent, this life-saving device has been used to treat coronary artery disease in nearly 100 million patients worldwide since its approval in 1994. It is considered one of the top 10 medical device patents of the past 50 years.

He will receive a SUNY Honorary Doctorate in Science.

Dr. Schatz is widely known as the father of modern interventional cardiology for good reason, Tripathi said. Every day, his groundbreaking work is realized in operating rooms across the country and beyond. The stent he co-created spurred a revolution in the treatment of coronary artery disease and, 30 years later, it has had an immeasurable impact on health care.

By contributing to society through his biomedical innovations and inventions, Dr. Schatz has improved the lives of tens of millions of people while embodying the ideals of our university community and our university system.

A New York native, Schatz is the research director of cardiovascular interventions at the Scripps Clinic and director of gene and stem cell therapy. He is an elected fellow of the American College of Cardiology; in 2019, he received the Fritz J. And Dolores H. Russ Prize, which recognizes biomedical engineering achievements that have significantly improved the human condition. He is also the recipient of the Barton Haynes Lifetime Scholar Award from Duke University Medical Center.

Schatz attended UB in the early 1970s before gaining early admission to Duke Medical School, then completed his cardiology training at Brooke Army Medical Center. Throughout his career, he has maintained a strong affinity for UB, crediting the universitys faculty and curriculum for inspiring him to pursue a career in medicine.

See more here:
Wilson to receive Norton Medal - UB Now: News and views for UB faculty and staff - University at Buffalo Reporter